-
1
-
-
84975525035
-
Clinical applications of research on angiogenesis
-
Folkman J: Clinical applications of research on angiogenesis. New Engl J Med 333: 1757-1763, 1995
-
(1995)
New Engl J Med
, vol.333
, pp. 1757-1763
-
-
Folkman, J.1
-
2
-
-
0023909330
-
Determinants of tumor blood flow: A review
-
Jain RK: Determinants of tumor blood flow: a review. Cancer Res 48: 2641-2658, 1988
-
(1988)
Cancer Res
, vol.48
, pp. 2641-2658
-
-
Jain, R.K.1
-
3
-
-
0024408986
-
Blood flow, oxygen and nutrient supply and metabolic microenvironment of human tumors: A review
-
Vaupel P, Kallinowski F, Okunieff P: Blood flow, oxygen and nutrient supply and metabolic microenvironment of human tumors: a review. Cancer Res 49: 6449-6465, 1989
-
(1989)
Cancer Res
, vol.49
, pp. 6449-6465
-
-
Vaupel, P.1
Kallinowski, F.2
Okunieff, P.3
-
4
-
-
0028028308
-
Angiogenesis inhibition: A review
-
Auerbach W, Auerbach R: Angiogenesis inhibition: a review. Pharmac Ther 63: 265-311, 1994
-
(1994)
Pharmac Ther
, vol.63
, pp. 265-311
-
-
Auerbach, W.1
Auerbach, R.2
-
5
-
-
0028912119
-
Controlling the vasculature: Angiogenesis, anti-angiogenesis and vascular targeting of gene therapy
-
Fan TD, Jaggar R, Bicknell R: Controlling the vasculature: angiogenesis, anti-angiogenesis and vascular targeting of gene therapy. Trends Pharmacol Sci 16: 57-66, 1995
-
(1995)
Trends Pharmacol Sci
, vol.16
, pp. 57-66
-
-
Fan, T.D.1
Jaggar, R.2
Bicknell, R.3
-
8
-
-
0028110421
-
Suramin inhibits glioma cell proliferation in vitro and in the brain
-
Takano S, Gately S, Engelhard H, Tsanaclis AMC, Brem S: Suramin inhibits glioma cell proliferation in vitro and in the brain. J Neuro-Oncol 21: 189-201, 1994
-
(1994)
J Neuro-Oncol
, vol.21
, pp. 189-201
-
-
Takano, S.1
Gately, S.2
Engelhard, H.3
Tsanaclis, A.M.C.4
Brem, S.5
-
9
-
-
0028318791
-
Suramin, an anticancer and angiosuppressive agent, inhibits endothelial cell binding to basic fibroblast growth factor, migration, proliferation and induction of urokinase-type plasminogen activator
-
Takano S, Gately S, Neville ME, Herblin W, Gross JL, Engelhard H, Perricone M, Eidsvoog K, Brem S: Suramin, an anticancer and angiosuppressive agent, inhibits endothelial cell binding to basic fibroblast growth factor, migration, proliferation and induction of urokinase-type plasminogen activator. Cancer Res 54: 2654-2660, 1994
-
(1994)
Cancer Res
, vol.54
, pp. 2654-2660
-
-
Takano, S.1
Gately, S.2
Neville, M.E.3
Herblin, W.4
Gross, J.L.5
Engelhard, H.6
Perricone, M.7
Eidsvoog, K.8
Brem, S.9
-
10
-
-
0028866065
-
Selective sensitivity of solid tumors to suramin in primary cultures of tumor cells from patients
-
Schrell UMH, Gauer S, Kiesewetter F, Bickel A, Hren J, Adams EF, Csoka K, Nygren P, Graf W, Pahlman L, Glimelius B, Larsson R: Selective sensitivity of solid tumors to suramin in primary cultures of tumor cells from patients. Br J Cancer 63: 356-360, 1995
-
(1995)
Br J Cancer
, vol.63
, pp. 356-360
-
-
Schrell, U.M.H.1
Gauer, S.2
Kiesewetter, F.3
Bickel, A.4
Hren, J.5
Adams, E.F.6
Csoka, K.7
Nygren, P.8
Graf, W.9
Pahlman, L.10
Glimelius, B.11
Larsson, R.12
-
11
-
-
0030891264
-
Suramin in non-small cell lung cancer and advanced breast cancer
-
Mirza MR, Jakobsen E, Pfeiffer P, Lindebjerg-Clasen B, Bergh J, Rose C: Suramin in non-small cell lung cancer and advanced breast cancer. Acta Oncologica 36: 171-174, 1997
-
(1997)
Acta Oncologica
, vol.36
, pp. 171-174
-
-
Mirza, M.R.1
Jakobsen, E.2
Pfeiffer, P.3
Lindebjerg-Clasen, B.4
Bergh, J.5
Rose, C.6
-
12
-
-
0015291143
-
Tumor angiogenesis: A quantitative method for histologic grading
-
Brem SS, Cotran R, Folkman J: Tumor angiogenesis: a quantitative method for histologic grading. J Natl Cancer Inst 48: 347-356, 1972
-
(1972)
J Natl Cancer Inst
, vol.48
, pp. 347-356
-
-
Brem, S.S.1
Cotran, R.2
Folkman, J.3
-
13
-
-
0029994483
-
Tumor oxygenation: A matter of supply and demand
-
Gulledge CJ, Dewhirst MW: Tumor oxygenation: a matter of supply and demand. Anticancer Res 16: 741-750, 1996
-
(1996)
Anticancer Res
, vol.16
, pp. 741-750
-
-
Gulledge, C.J.1
Dewhirst, M.W.2
-
14
-
-
0028873333
-
Vascular permeability factor expression influences tumor angiogenesis in human melanoma lines xenografted to nude mice
-
Potgens AJG, Lubsen NH, van Altena MC, Schoenmakers JCG, Ruiter DJ, de Waal RMW: Vascular permeability factor expression influences tumor angiogenesis in human melanoma lines xenografted to nude mice. Am J Pathol 146: 197-209, 1995
-
(1995)
Am J Pathol
, vol.146
, pp. 197-209
-
-
Potgens, A.J.G.1
Lubsen, N.H.2
Van Altena, M.C.3
Schoenmakers, J.C.G.4
Ruiter, D.J.5
De Waal, R.M.W.6
-
15
-
-
8544221117
-
Vascular density in melanoma xenografts correlates with vascular permeability factor expression but not with metastatic potential
-
Westphal JR, van 't Hullenaar RGM, van der Laak JAWM, Cornelissen IMHA, Schalkwijk LJM, van Muijen GNP, Wesseling P, de Wilde PCM, Ruiter DJ, de Waal RMW: Vascular density in melanoma xenografts correlates with vascular permeability factor expression but not with metastatic potential. Br J Cancer 76: 561-570, 1997
-
(1997)
Br J Cancer
, vol.76
, pp. 561-570
-
-
Westphal, J.R.1
Van 't Hullenaar, R.G.M.2
Van Der Laak, J.A.W.M.3
Cornelissen, I.M.H.A.4
Schalkwijk, L.J.M.5
Van Muijen, G.N.P.6
Wesseling, P.7
De Wilde, P.C.M.8
Ruiter, D.J.9
De Waal, R.M.W.10
-
16
-
-
0029150035
-
Application of an image analysis system for the quantitation of the tumor perfusion and vascularity in human glioma xenografts
-
Rijken PFJW, Bernsen HJJA, van der Kogel AJ: Application of an image analysis system for the quantitation of the tumor perfusion and vascularity in human glioma xenografts. Microvasc Res 50: 141-153, 1995
-
(1995)
Microvasc Res
, vol.50
, pp. 141-153
-
-
Rijken, P.F.J.W.1
Bernsen, H.J.J.A.2
Van Der Kogel, A.J.3
-
17
-
-
0030940609
-
Suramin: A molecule with a broad spectrum of biological and therapeutical properties
-
Baghdiguian S, Fantini J: Suramin: a molecule with a broad spectrum of biological and therapeutical properties. Cancer J 10: 31-37, 1997
-
(1997)
Cancer J
, vol.10
, pp. 31-37
-
-
Baghdiguian, S.1
Fantini, J.2
-
18
-
-
0026352044
-
Receptors for platelet derived growth factor in human glioma lines and influence of suramin on cell proliferation
-
Westphal M, Ackerman E, Hoppe J, Herrmann HD: Receptors for platelet derived growth factor in human glioma lines and influence of suramin on cell proliferation. J Neuro-Oncol 11: 207-213, 1991
-
(1991)
J Neuro-Oncol
, vol.11
, pp. 207-213
-
-
Westphal, M.1
Ackerman, E.2
Hoppe, J.3
Herrmann, H.D.4
-
19
-
-
0026729378
-
Suramin prevents neovascularization and tumor growth through blocking of fibroblast growth factor activity
-
Pesenti E, Sola F, Mongelli N, Grandi M, Spreafico F: Suramin prevents neovascularization and tumor growth through blocking of fibroblast growth factor activity. Br J Cancer 66: 367-372, 1992
-
(1992)
Br J Cancer
, vol.66
, pp. 367-372
-
-
Pesenti, E.1
Sola, F.2
Mongelli, N.3
Grandi, M.4
Spreafico, F.5
-
20
-
-
0026640068
-
Nature of the interaction of growth factors with suramin
-
Middaugh CR, Mach H, Burke CJ, Volkin DB, Dabora JM, Tsai PK, Bruner MW, Ryan JA, Marfia KE: Nature of the interaction of growth factors with suramin. Biochemistry 31: 9016-9024, 1992
-
(1992)
Biochemistry
, vol.31
, pp. 9016-9024
-
-
Middaugh, C.R.1
Mach, H.2
Burke, C.J.3
Volkin, D.B.4
Dabora, J.M.5
Tsai, P.K.6
Bruner, M.W.7
Ryan, J.A.8
Marfia, K.E.9
-
21
-
-
0027162784
-
Suramin, an anticancer drug with unique biological effects
-
Larsen AK: Suramin, an anticancer drug with unique biological effects. Cancer Chemother Pharmacol 32: 96-98, 1993
-
(1993)
Cancer Chemother Pharmacol
, vol.32
, pp. 96-98
-
-
Larsen, A.K.1
-
22
-
-
0028345444
-
A structure-activity analysis of antagonism of growth factor and angiogenesis activity of basic fibroblast growth factor by suramin and related polyanions
-
Braddock PS, Hu DE, Fan TPD, Stratford IJ, Harris AL, Bicknell R: A structure-activity analysis of antagonism of growth factor and angiogenesis activity of basic fibroblast growth factor by suramin and related polyanions. Br J Cancer 69: 890-898, 1994
-
(1994)
Br J Cancer
, vol.69
, pp. 890-898
-
-
Braddock, P.S.1
Hu, D.E.2
Fan, T.P.D.3
Stratford, I.J.4
Harris, A.L.5
Bicknell, R.6
-
23
-
-
0030198685
-
Suramin is a potent inhibitor of vascular endothelial growth factor. a contribution to the molecular basis of its antiangiogenic action
-
Waltenberger J, Mayr U, Frank H, Hombach V: Suramin is a potent inhibitor of vascular endothelial growth factor. A contribution to the molecular basis of its antiangiogenic action. J Mol Cell Cardiol 28: 1523-1529, 1996
-
(1996)
J Mol Cell Cardiol
, vol.28
, pp. 1523-1529
-
-
Waltenberger, J.1
Mayr, U.2
Frank, H.3
Hombach, V.4
-
24
-
-
0029397222
-
Angiogenesis in malignant gliomas
-
Plate KH, Risau W: Angiogenesis in malignant gliomas. Glia 15: 339-347, 1995
-
(1995)
Glia
, vol.15
, pp. 339-347
-
-
Plate, K.H.1
Risau, W.2
-
25
-
-
0029074334
-
Suramin inhibits C6 glioma-induced angiogenesis in vitro
-
Coomber BL: Suramin inhibits C6 glioma-induced angiogenesis in vitro. J Cell Biochem 58: 199-207, 1995
-
(1995)
J Cell Biochem
, vol.58
, pp. 199-207
-
-
Coomber, B.L.1
-
26
-
-
0028044984
-
The efficacy and distribution of suramin in the treatment of the 9L gliosarcoma
-
Olson JJ, Polk DM, Reisner A: The efficacy and distribution of suramin in the treatment of the 9L gliosarcoma. Neurosurgery 34: 297-308, 1994
-
(1994)
Neurosurgery
, vol.34
, pp. 297-308
-
-
Olson, J.J.1
Polk, D.M.2
Reisner, A.3
-
27
-
-
0028978344
-
Stimulation of tumor growth in vitro and in vivo by suramin on the VX2 model
-
Ramirez LH, Julieron M, Bonnay M, Koscielny S, Zhao Z, Gouyette A, Munck JN: Stimulation of tumor growth in vitro and in vivo by suramin on the VX2 model. Investigational New Drugs 13: 51-53, 1995
-
(1995)
Investigational New Drugs
, vol.13
, pp. 51-53
-
-
Ramirez, L.H.1
Julieron, M.2
Bonnay, M.3
Koscielny, S.4
Zhao, Z.5
Gouyette, A.6
Munck, J.N.7
-
28
-
-
0027197245
-
Inhibition of VEGF-induced angiogenesis suppresses tumor growth in vivo
-
Kim KJ, Li B, Winer J, Armanini M, Gillet N, Phillips HS, Ferrara N: Inhibition of VEGF-induced angiogenesis suppresses tumor growth in vivo. Nature 362: 841-844, 1993
-
(1993)
Nature
, vol.362
, pp. 841-844
-
-
Kim, K.J.1
Li, B.2
Winer, J.3
Armanini, M.4
Gillet, N.5
Phillips, H.S.6
Ferrara, N.7
-
29
-
-
0028111148
-
Anti-proliferative effects of TNP-470 on human malignant glioma in vivo: Potent inhibition of angiogenesis
-
Taki T, Ohnishi T, Arita N, Hiaga S, Saitoh Y, Izumotot S, Mori K, Hayakawa T: Anti-proliferative effects of TNP-470 on human malignant glioma in vivo: potent inhibition of angiogenesis. J Neuro-Oncol 19: 251-258, 1994
-
(1994)
J Neuro-Oncol
, vol.19
, pp. 251-258
-
-
Taki, T.1
Ohnishi, T.2
Arita, N.3
Hiaga, S.4
Saitoh, Y.5
Izumotot, S.6
Mori, K.7
Hayakawa, T.8
-
30
-
-
0029949160
-
Time-dependent vascular regression and permeability changes in established human tumor xenografts induced by an anti-vascular endothelial growth factor/vascular permeability factor antibody
-
Yuan F, Chen Y, Dellian M, Safabakhsh N, Ferrara N, Jain RK: Time-dependent vascular regression and permeability changes in established human tumor xenografts induced by an anti-vascular endothelial growth factor/vascular permeability factor antibody. Proc Natl Acad Sci 93: 14765-14770, 1996
-
(1996)
Proc Natl Acad Sci
, vol.93
, pp. 14765-14770
-
-
Yuan, F.1
Chen, Y.2
Dellian, M.3
Safabakhsh, N.4
Ferrara, N.5
Jain, R.K.6
-
31
-
-
0029863730
-
Dominant-negative inhibition of Flk-1 suppresses the growth of many tumor types in vivo
-
Millauer B, Longhi MP, Plate KH, Shawver LK, Risau W, Ullrich A, Strawn LM: Dominant-negative inhibition of Flk-1 suppresses the growth of many tumor types in vivo. Cancer Res 56: 1615-1620, 1996
-
(1996)
Cancer Res
, vol.56
, pp. 1615-1620
-
-
Millauer, B.1
Longhi, M.P.2
Plate, K.H.3
Shawver, L.K.4
Risau, W.5
Ullrich, A.6
Strawn, L.M.7
-
32
-
-
0031909427
-
The effect of the anti-angiogenic agent AGM-1470 on tumor growth and vascularity in low passaged xenografts of human gliomas in nude mice
-
Bernsen HJJA, Rijken PFJW, Peters H, Bakker H, van der Kogel AJ: The effect of the anti-angiogenic agent AGM-1470 on tumor growth and vascularity in low passaged xenografts of human gliomas in nude mice. J Neuro-Oncol 38: 51-57, 1998
-
(1998)
J Neuro-Oncol
, vol.38
, pp. 51-57
-
-
Bernsen, H.J.J.A.1
Rijken, P.F.J.W.2
Peters, H.3
Bakker, H.4
Van Der Kogel, A.J.5
-
33
-
-
84982729034
-
Antiangiogenic agents can increase tumor oxygenation and responses to radiation therapy
-
Teicher BA, Dupuis N, Kusomoto T, Robinson MF, Liu F, Menon K, Coleman CN: Antiangiogenic agents can increase tumor oxygenation and responses to radiation therapy. Radiat Oncol Invest 2: 269-276, 1995
-
(1995)
Radiat Oncol Invest
, vol.2
, pp. 269-276
-
-
Teicher, B.A.1
Dupuis, N.2
Kusomoto, T.3
Robinson, M.F.4
Liu, F.5
Menon, K.6
Coleman, C.N.7
-
34
-
-
0030920374
-
Preclinical studies of the combination of angiogenic inhibitors with cytotoxic agents
-
Kakeji Y, Teicher BA: Preclinical studies of the combination of angiogenic inhibitors with cytotoxic agents. Investigational New Drugs 15: 39-48, 1997
-
(1997)
Investigational New Drugs
, vol.15
, pp. 39-48
-
-
Kakeji, Y.1
Teicher, B.A.2
-
35
-
-
0029875694
-
Uptake of tenozolomide in a rat glioma model in presence or absence of the angiogenesis inhibitor TNP-470
-
Devineni D, Kleinszanto A, Gallo JM: Uptake of tenozolomide in a rat glioma model in presence or absence of the angiogenesis inhibitor TNP-470. Cancer Res 56: 1983-1987, 1996
-
(1996)
Cancer Res
, vol.56
, pp. 1983-1987
-
-
Devineni, D.1
Kleinszanto, A.2
Gallo, J.M.3
-
36
-
-
0028840752
-
Antiproliferative and angiostatic activity of suramine analogues
-
Firsching A, Nickel P, Mor AP, Allolio B: Antiproliferative and angiostatic activity of suramine analogues. Cancer Res 55: 4957-4962, 1995
-
(1995)
Cancer Res
, vol.55
, pp. 4957-4962
-
-
Firsching, A.1
Nickel, P.2
Mor, A.P.3
Allolio, B.4
-
37
-
-
0031905878
-
Antiangiogenic and antiproliferative activity of suramin analogues
-
Gagliardi ART, Kassack M, Kreimeyer A, Muller G, Nickel P, Collins DC: Antiangiogenic and antiproliferative activity of suramin analogues. Cancer Chemother Pharmacol 41: 117-124, 1998
-
(1998)
Cancer Chemother Pharmacol
, vol.41
, pp. 117-124
-
-
Gagliardi, A.R.T.1
Kassack, M.2
Kreimeyer, A.3
Muller, G.4
Nickel, P.5
Collins, D.C.6
-
38
-
-
0032016531
-
Sulfanilic acid-, Benzenedisulfonic acid-, and Naphthalenetrisulfonic acid analogues
-
Kreimeyer A, Muller G, Kassack M, Nickel P, Gagliardi ART: Sulfanilic acid-, Benzenedisulfonic acid-, and Naphthalenetrisulfonic acid analogues. Arch Pharm Pharm Med Chem 331: 97-103, 1998
-
(1998)
Arch Pharm Pharm Med Chem
, vol.331
, pp. 97-103
-
-
Kreimeyer, A.1
Muller, G.2
Kassack, M.3
Nickel, P.4
Gagliardi, A.R.T.5
|